Amgen Inc. buy Royal Bank of Canada
Start price
15.01.26
/
50%
€284.25
Target price
15.01.27
€287.83
Performance (%)
5.28%
Price
09:20
€299.00
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 5.28%. A total of €2.52 was paid as dividends for this prediction. This prediction currently runs until 15.01.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 0.624% | 0.624% |
| iShares Core DAX® | -0.201% | 5.471% |
| iShares Nasdaq 100 | 2.573% | 10.092% |
| iShares Nikkei 225® | 0.598% | 9.871% |
| iShares S&P 500 | 1.804% | 7.404% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Royal Bank Of Canada from $330.00 to $335.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat